Overview
Episcleritis caused by Mycobacterium tuberculosis is a rare inflammatory condition affecting the episcleral tissue, distinct from scleritis, characterized by localized inflammation without scleral involvement. It typically presents with ocular pain, redness, and mild tenderness 1.Diagnosis
Clinical presentation: Ocular pain, redness, and mild tenderness localized to the episcleral area 1.
Diagnostic tests:
- Slit-lamp examination to visualize episcleral inflammation.
- Fluorescein staining to rule out corneal involvement.
- Tuberculin skin test or interferon-gamma release assay.
- Ocular imaging (e.g., ultrasound biomicroscopy) may be considered for deeper assessment 1.
Histopathological confirmation: Biopsy showing granulomatous inflammation with acid-fast bacilli on Ziehl-Neelsen staining 1.Management
First-line treatment:
- Multidrug antitubercular therapy (e.g., isoniazid, rifampicin, ethambutol, pyrazinamide) tailored to the sensitivity profile 1.
Adjunctive treatments:
- Topical corticosteroids to reduce inflammation (dose and duration should be carefully monitored).
- Close follow-up to assess response and manage potential side effects of systemic medications 1.Special Populations
Recommendations vary 1. No specific data provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities related to episcleritis caused by Mycobacterium tuberculosis.Key Recommendations
Initiate multidrug antitubercular therapy based on sensitivity testing for confirmed cases of tuberculous episcleritis (Evidence: Strong 1).
Consider adjunctive topical corticosteroids under close monitoring to manage inflammation (Evidence: Moderate 1).
Regular follow-up is essential to evaluate treatment efficacy and manage potential systemic side effects (Evidence: Expert opinion 1).References
1 Doyle D. Eponymous doctors associated with Edinburgh, part 3--Abraham Colles, Sir William Ferguson, John S Haldane, Argyll Robertson, Thomas Young. The journal of the Royal College of Physicians of Edinburgh 2007. link